Hypertension in women

Area of Science:

• Cardiology
• Gerontology
• Public Health

Background:

• Hypertension in women is understudied compared to men, with limited data on prevalence, complications, and treatment efficacy.
• While overall morbidity and mortality from hypertension are lower in women than men, the risk increases significantly with age, particularly in postmenopausal women.
• Hypertensive women experiencing myocardial infarction have a poorer prognosis than men.

Purpose of the Study:

• To review the current understanding of hypertension in women, including prevalence, associated risks, and treatment outcomes.
• To highlight the effectiveness of antihypertensive treatments in elderly women based on existing clinical trials.
• To identify gaps in research, particularly concerning newer antihypertensive agents in women.

Main Methods:

• Review of existing epidemiological studies (e.g., Framingham Study, Hypertension Detection and Follow-up Program).
• Analysis of data from large-scale clinical trials in elderly hypertensive patients (e.g., EWPHE, SHELL, STOP-HTN, MRC 1992).
• Identification of research gaps regarding the use of novel antihypertensive medications in women.

Main Results:

• Blood pressure increases with age in both sexes; hypertension is more prevalent in men overall, but common in postmenopausal women.
• Elderly hypertensive patients treated in major trials showed significant reductions in all-cause mortality (30%), stroke (33%), and heart failure (40-50%).
• Current evidence on newer antihypertensive agents (calcium channel blockers, ACE inhibitors) in women is lacking.

Conclusions:

• Antihypertensive treatment is effective in reducing mortality and cardiovascular events in elderly hypertensive women.
• Smoking cessation is a critical intervention for hypertensive women, especially smokers.
• Further research is essential to evaluate the efficacy and safety of newer antihypertensive drugs in the female population.